Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.26.3
Stock-Based Compensation (Tables)
6 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of weighted-average assumptions
     
Six Months Ended September 30, 2026   Assumptions  
Fair value of the Company’s common stock on date of grant   $ 1.26  
Expected term     5-6.5 years  
Risk-free interest rate     4.54%  
Dividend yield     0%  
Volatility     112.12% to 115.28%  
Fair value of options granted   $ 1.19  

 

Six Months Ended September 30, 2025   Assumptions  
Fair value of the Company’s common stock on date of grant   $ 2.85  
Expected term     5 years  
Risk-free interest rate     4.38%  
Dividend yield     0%  
Volatility     112.56%  
Fair value of options granted   $ 2.32  
Schedule of stock options award activity
           
    Number of
Shares
    Weighted-
Average
Exercise Price
 
Outstanding at April 1, 2026     129,163     $ 23.94  
Options granted     62,500       1.26  
Options exercised     (2,500 )     1.26  
Options expired     (12 )     837.00  
Outstanding at September 30, 2026     189,151       16.69  
Exercisable at September 30, 2026     102,151     $ 28.66  
Schedule of restricted stock award activity
           
   

Number of

Shares

   

Weighted

Average Award

Date Fair Value

per Share

 
Unvested restricted stock awards outstanding at April 1, 2026     118,000     $ 3.04  
Restricted stock awards granted     56,431       1.35  
Vested restricted stock awards     (6,431 )     2.17  
Unvested restricted stock awards outstanding at September 30, 2026     168,000     $ 2.51